Skip to main content [aditude-amp id="stickyleaderboard" targeting='{"env":"staging","page_type":"article","post_id":88943,"post_type":"story","post_chan":"none","tags":null,"ai":false,"category":"none","all_categories":"business,","session":"B"}']

23andMe allows a peek at its genomics service, minus the $999 fee

23andMe allows a peek at its genomics service, minus the $999 fee

23andMe — the Google-backed startup that scans your genome for disease-risk factors and other information, now lets anyone see how the service works without first charging $999 for the privilege. My first impression: It packs a tremendous amount of information into clean, uncluttered pages that are still relatively easy to understand even for newcomers to genetics.

The 23andMe service stands in particularly sharp contrast to a similar offering from deCODEme, which I reviewed unfavorably here and here. We take a closer look in this post over at VentureBeat Life Sciences.

[aditude-amp id="flyingcarpet" targeting='{"env":"staging","page_type":"article","post_id":88943,"post_type":"story","post_chan":"none","tags":null,"ai":false,"category":"none","all_categories":"business,","session":"B"}']

VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative enterprise technology and transact. Learn More